AI in GI

AI is now embedded in routine endoscopy, with CADe systems (GI Genius, ENDO-AID, CAD EYE) demonstrating consistent adenoma detection rate (ADR) gains in randomized trials and real-world registries. CADx optical biopsy is approaching a credible diagnose-and-leave or resect-and-discard strategy for diminutive polyps. The track covers AI for Barrett’s neoplasia, capsule endoscopy reading, ulcerative colitis endoscopic Mayo scoring, and histopathology deep-learning models for dysplasia and MSI prediction. Implementation sessions address regulatory pathways (FDA SaMD, EU MDR), bias and generalizability, prospective ADR drift studies, and integration with electronic health records.